Specify a stock or a cryptocurrency in the search bar to get a summary
Cyclopharm Ltd
CYCCyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, and internationally. The company operates through Technegas and Molecular Imaging segments. The Technegas segment offers diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism. This segment also distributes products to the diagnostic imaging sector. The Molecular Imaging segment provides radiopharmaceuticals that are used by physicians in the detection of cancer, neurological disorders, and cardiac diseases. The company serves nuclear medicine departments. Cyclopharm Limited was founded in 1986 and is headquartered in Kingsgrove, Australia. Address: 1 The Crescent, Kingsgrove, NSW, Australia, 2208
Analytics
WallStreet Target Price
4.19 AUDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures CYC
Dividend Analytics CYC
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
-18 %Dividend History CYC
Stock Valuation CYC
Financials CYC
Results | 2019 | Dynamics |